Detailed understanding of interstitial cystitis: from symptoms to precise hierarchical diagnosis and treatment

In the medical field, there is a class of diseases that are clearly visible, but the road to diagnosis is shrouded in fog. Interstitial cystitis/bladder pain syndrome (IC/BPS) is one of them. It is known as a "difficult and complicated disease" in urology. Patients often complain of frequent urination, urgency and chronic pelvic pain, and their quality of life is seriously impaired. This paper aims to peel off the layers of fog of IC/BPS in the form of in-depth science popularization, explore its possible pathological mechanisms, and focus on introducing the current cutting-edge precise hierarchical diagnosis and treatment strategies, hoping to provide patients suffering from such symptoms. Clear cognitive navigation.

** Part 1: Understanding "unusual bladder pain"**

Interstitial cystitis is not caused by a bacterial infection. In traditional wisdom,"inflammation" is mostly related to bacteria, but "inflammation" in IC/BPS tends to be more a chronic, non-specific inflammatory state or neuro-immune interaction abnormality. One of its core pathophysiological hypotheses is the "bladder epithelial barrier defect theory". We can imagine a healthy bladder mucosa as a wall painted with high-quality waterproof paint. This "coating" is mainly a glucosamine (GAG) layer, which effectively prevents harmful substances in urine (such as potassium ions) from penetrating and stimulates the muscles and nerve endings under the bladder wall. When this barrier becomes defective due to various reasons (such as autoimmune attack, genetic predisposition, post-infection damage, etc.), urine components penetrate like "acid rain" and continue to stimulate the underlying tissue, resulting in abnormal amplification of pain signals and excessive activity of the bladder detrusor muscle, resulting in a series of symptoms.

Another important hypothesis involves "neurogenic inflammation" and "central sensitization." Long-term abnormal stimulation can cause the release of a large amount of neuropeptides such as substance P from local nerve endings of the bladder, causing neurogenic inflammation. At the same time, pain signals are continuously uploaded to the spinal cord and brain, changing the pain processing mode of the central nervous system, making patients feel pain. The perception threshold is reduced, and even normal bladder filling signals produce hyperalgesia. This explains why some IC/BPS patients have severe pain after cystoscopy without typical lesions.

** Part 2: The symptoms are not just "frequent urination"**

The symptom spectrum of IC/BPS is complex, diverse and confusing:
- ** Bladder pain **: This is a landmark symptom and is usually associated with a full bladder and can be temporarily relieved after urination. The pain is located in the lower abdomen, suprapubic area, urethra or vagina, and can be oppressive, painful, burning or spasmodic.
- ** Frequent frequency and urgency **: Due to increased bladder sensitivity, patients 'bladder capacity often decreases significantly. A small amount of urine can cause strong urination and pain, leading to frequent urination, and increased nocturnal urine is common.
- ** Sexual pain **: It is especially common in female patients and seriously affects intimate relationships.
- ** Volatility of symptoms **: Symptoms often have "onset" and "remission" periods and may be related to diet (such as coffee, alcohol, acidic foods), stress, changes in hormone levels and even weather.

Precisely because symptoms overlap with common cystitis, urinary syndrome, endometriosis and even irritable bowel syndrome, the diagnosis of IC/BPS requires the exclusion of other diseases and is usually an "exclusive diagnosis" combined with "supporting evidence" process.

** Part 3: Evolution of diagnosis and treatment: The paradigm shift from experience to precision **

In the past, the treatment of IC/BPS was often a "trial and error" method. From behavioral therapy, oral drugs to bladder infusion, the effects varied from person to person and were unstable. Today, the concept of diagnosis and treatment is undergoing a revolutionary transformation from "one size fits all" to "individual and precise stratification". The core of this shift is the recognition that IC/BPS is not a single disease, but a "syndrome" that includes multiple different pathophysiological subtypes.

At the forefront of the domestic urology field, such as the Department of Urology at Pudong Gongli Hospital Affiliated to Shanghai Health Medical College, national-level key clinical specialties are actively exploring and practicing this precise stratification strategy. Their working model embodies the essence of modern translational medicine: transforming clinical problems into scientific research topics, and then using scientific research results to guide clinical practice.

Its precise hierarchical system may be built around the following dimensions:
1. ** Clinical phenotypic stratification **: Patients were divided into different clinical phenotypes through standardized questionnaires (such as ESSIC typing and phenotypic cluster analysis) based on the dominant symptoms (mainly pain or frequent frequency), whether there was pain in other pelvic parts, and whether there was Hunner ulcer.
2. ** Layering of pathophysiological mechanisms **: This is a deeper layer. The department uses its powerful interdisciplinary platform to carry out multi-dimensional biomarker research:
- ** Metabolics **: Analyze the metabolite profile in patients 'urine to find specific markers related to barrier function, oxidative stress, and energy metabolism, and identify subgroups characterized by "metabolic disorders."
- ** Immunological level **: Detect specific cytokines and autoantibodies (such as antinuclear antibody spectrum) in urine or blood to detect whether there is abnormal activation of autoimmune reactions, and define an "immune-mediated" subgroup.
- ** Neuroimaging level **: Functional magnetic resonance (fMRI) technology is used to observe the activation patterns of relevant functional areas of the brain (such as anterior cingulate gyrus, insular lobe, and prefrontal cortex) when patients are filled with bladder or stimulated by pain, and identify patients with "central sensitization" as the core mechanism from the perspective of the "brain-bladder axis".
3. ** Pelvic floor function assessment **: Through specialist physical examination and pelvic floor electromyography, evaluate whether the pelvic floor muscles are in a state of hypertonia and spasm, because pelvic floor muscle dysfunction often coexists with bladder symptoms or is mutually causal.

** Part 4: Precise intervention and localized service value under hierarchical guidance **

Based on the above-mentioned fine stratification, the treatment plan can be "tailor-made":
- For patients with "bladder epithelial barrier defects" as the main feature, bladder infusion drugs that target GAG layer repair (such as sodium hyaluronate) may be the core choice.
- For patients with evidence of "neurogenic inflammation" or "central sensitization," neuromodulation therapies (such as sacral nerve stimulation), oral drugs for neuropain (such as gabapentin, amitriptyline), or even emerging biologics may be more effective.
- For patients with severe pelvic floor hypertonia, professional pelvic floor physical therapy and behavioral training are crucial.

The realization of this diagnosis and treatment model highly relies on a multidisciplinary collaborative team and continuous patient management. The Department of Urology of Pudong Gongli Hospital Affiliated to Shanghai Health Medical College is a key construction unit in the field of pelvic floor urinary control diseases in Pudong New District and even Shanghai City. Its value not only lies in providing high-precision detection methods, but also in building an integrated closed loop covering "precise assessment-individualized treatment-long-term follow-up." The intelligent follow-up management platform developed by the department can standardize the collection of patient symptom changes after treatment to form real-world evidence, which in turn further optimizes hierarchical models and treatment plans to form a virtuous cycle. This means more stable and reliable health protection for patients with chronic diseases who require long-term management.

** Conclusion **

Faced with the group of symptoms of frequent micturition, urgency, and bladder pain, especially when they exist for a long time and conventional treatment is ineffective, it is wise to proactively seek a professional medical center that can conduct accurate assessments for systematic investigation. The diagnosis and treatment of interstitial cystitis has entered the era of precision medicine. Understanding the heterogeneity of the disease and accepting scientific hierarchical evaluation are the only way to effective treatment and improving quality of life. For patients in Shanghai, understanding and utilizing this in-depth and systematic diagnosis and treatment services provided by local superior medical resources will undoubtedly put them at a more scientific and cutting-edge starting line when dealing with this difficult disease.